Dr. Dimosthenis Chochlakis | Epidemiology of Emerging | Best Researcher Award

Dr. Dimosthenis Chochlakis | Epidemiology of Emerging | Best Researcher Award

Dr. Dimosthenis Chochlakis | Epidemiology of Emerging - School of Medicine/University of Crete,Greece

Dimosthenis Chochlakis is a leading expert in the Epidemiology of Emerging pathogens, extensively contributing to public health through surveillance, diagnostics, and applied microbiology. His work spans over two decades, involving advanced research in molecular microbiology, public health, and zoonoses. With profound experience in the Epidemiology of Emerging infections, especially vector-borne and zoonotic diseases, he has shaped both national and international policies. He has delivered outstanding contributions to the Epidemiology of Emerging outbreaks and public health readiness, always highlighting the Epidemiology of Emerging risks related to environmental and vector-related sources. Through publications and collaborative research, he has advanced the scientific understanding of the Epidemiology of Emerging diseases. Dr. Chochlakis consistently integrates surveillance systems into real-time diagnostics focusing on the Epidemiology of Emerging bacteria and pathogens. His leadership roles have made him a key figure in promoting strategic frameworks for the Epidemiology of Emerging threats. The consistent drive for addressing global challenges related to the Epidemiology of Emerging pathogens underscores his academic and scientific influence. Dr. Chochlakis continues to promote interdisciplinary solutions in the Epidemiology of Emerging diseases domain through research, education, and translational diagnostics of the Epidemiology of Emerging microorganisms.

AUTHOR PROFILE 

ORCID | SCOPUS

EDUCATION

Dimosthenis Chochlakis’s educational foundation is firmly rooted in the Epidemiology of Emerging pathogens. He earned a PhD in Molecular Microbiology from the University of Crete with research focused on the Epidemiology of Emerging vector-borne diseases. His earlier education includes a BSc and MSc from the University of Surrey, where he explored the Epidemiology of Emerging infections using biochemical and molecular tools. Throughout his studies, his academic path remained tightly linked with the Epidemiology of Emerging pathogens and their impact on public and veterinary health. His doctoral research contributed to key discoveries in the Epidemiology of Emerging zoonoses, especially in the Mediterranean region. Dr. Chochlakis combined theoretical knowledge with applied science, always anchored in the Epidemiology of Emerging disease surveillance. His continuous learning through seminars and certifications on diagnostic methods in Epidemiology of Emerging infections fortified his capabilities. This education positioned him as a leader in understanding and combating the Epidemiology of Emerging microbial threats, while promoting innovation in academic and public health strategies concerning the Epidemiology of Emerging diseases landscape.

PROFESSIONAL EXPERIENCE

Dr. Chochlakis has amassed exceptional professional experience centered around the Epidemiology of Emerging pathogens. From his long-standing role at the Laboratory of Clinical Bacteriology, Parasitology, Zoonoses, and Geographical Medicine at the University of Crete to national collaborations, he has tackled challenges in the Epidemiology of Emerging infectious diseases. His work in microbiology and public health laboratories has shaped Greece’s response to the Epidemiology of Emerging zoonotic outbreaks. Across teaching roles and diagnostic research programs, his emphasis on the Epidemiology of Emerging bacteria remained unwavering. He was pivotal in implementing surveillance systems and outbreak response frameworks based on the Epidemiology of Emerging risk factors. His diagnostic acumen and managerial roles have continuously reinforced the Epidemiology of Emerging research agenda. Collaborating with multiple stakeholders, Dr. Chochlakis ensures that the Epidemiology of Emerging threats are monitored and mitigated effectively. His clinical and academic activities blend seamlessly to serve the evolving needs of the Epidemiology of Emerging risk landscape.

RESEARCH INTEREST

The Epidemiology of Emerging diseases is at the core of Dr. Chochlakis's research. He specializes in studying the Epidemiology of Emerging zoonotic pathogens, vector-borne bacteria, and antimicrobial resistance. His research spans molecular epidemiology, surveillance methodologies, and environmental microbiology, all focused on the Epidemiology of Emerging challenges. Projects under his guidance have investigated Legionella, Anaplasma, Q fever, and Rickettsia with an emphasis on understanding the Epidemiology of Emerging pathogens’ behavior across ecosystems. He leads investigations exploring pathogen interactions, vector dynamics, and diagnostic innovations contributing to the Epidemiology of Emerging insights. He also applies genomics and proteomics to decode the Epidemiology of Emerging infectious agents. His academic drive continually aims to identify control points within the Epidemiology of Emerging pathogen spread. His research outputs help refine early-warning systems and surveillance models for Epidemiology of Emerging threats in Europe and beyond. Through cross-disciplinary collaborations, Dr. Chochlakis advances the global knowledge base on the Epidemiology of Emerging infections and their societal impact.

AWARD AND HONOR

Dr. Dimosthenis Chochlakis’s contributions to the Epidemiology of Emerging pathogens have earned him significant recognition. He has been a guest editor for scientific journals on the Epidemiology of Emerging topics and has received national and European acknowledgments for his leadership in infectious disease surveillance. His selection as a COST Action member reinforces his expertise in the Epidemiology of Emerging threats. He has also served on major committees evaluating research funding applications focused on the Epidemiology of Emerging diseases. These honors affirm his scientific impact and leadership within the Epidemiology of Emerging academic community. His invited lectures, editorial roles, and reviewer appointments are all testimony to his authority in the Epidemiology of Emerging domain. Furthermore, his role in conference organization and curriculum development for infectious disease courses strengthens his standing as a global expert in the Epidemiology of Emerging pathogens. These distinctions reflect his pioneering vision and ongoing contributions to the Epidemiology of Emerging threats.

RESEARCH SKILL

Dr. Chochlakis’s research skills are deeply anchored in the Epidemiology of Emerging microbiological challenges. He masters techniques such as molecular diagnostics, GIS mapping, MALDI-TOF MS, and proteomic identification to study the Epidemiology of Emerging organisms. He excels in laboratory diagnostics and field epidemiology concerning the Epidemiology of Emerging outbreaks. He uses advanced sequencing technologies and data interpretation software to investigate the Epidemiology of Emerging infections at both environmental and clinical interfaces. His training in microbial isolation, pathogen surveillance, and biostatistical evaluation equips him to address the complexity of the Epidemiology of Emerging disease scenarios. Dr. Chochlakis mentors students and researchers in laboratory best practices related to the Epidemiology of Emerging disease surveillance. He ensures that research quality is maintained across every phase of the Epidemiology of Emerging data pipeline. His multidisciplinary skills allow the transformation of research data into actionable public health insights focused on the Epidemiology of Emerging risks.

PUBLICATIONS

Dr. Chochlakis has an extensive publication record highlighting the Epidemiology of Emerging bacterial infections. His over 70 peer-reviewed journal articles and book chapters span topics like Legionella, Anaplasma, Rickettsiae, and Q fever—all central to the Epidemiology of Emerging diseases. His publications address molecular surveillance, resistance trends, diagnostic innovations, and environmental monitoring related to the Epidemiology of Emerging pathogens. With frequent appearances in high-impact journals, his work contributes to defining standards in Epidemiology of Emerging research. Many of his papers serve as reference studies in the global understanding of the Epidemiology of Emerging infections. He has co-authored with prominent scientists worldwide to expand the reach of Epidemiology of Emerging analyses. His citation metrics and h-index reflect the scientific community’s recognition of his authoritative voice in Epidemiology of Emerging issues. Through data-driven analysis and empirical insights, Dr. Chochlakis has created a rich body of literature that will continue to influence Epidemiology of Emerging disease preparedness.

  •  Title: Comparative Risk Assessment of Legionella spp. Colonization in Water Distribution Systems Across Hotels, Passenger Ships, and Healthcare Facilities During the COVID-19 Era
    Authors: Antonios Papadakis; Eleftherios Koufakis; Elias Ath Chaidoutis; Dimosthenis Chochlakis; Anna Psaroulaki
    Journal: Water

 

  • Title: Recreational Water Safety in Hotels: Lessons from the COVID-19 Pandemic and the Way Forward for a Safe Aquatic Environment
    Authors: Antonios Papadakis; Dimosthenis Chochlakis; Eleftherios Koufakis; Vilelmine Carayanni; Anna Psaroulaki
    Journal: Tourism and Hospitality

 

  • Title: A Customizable Multiplex Protein Microarray for Antibody Testing and Its Application for Tick-Borne and Other Infectious Diseases
    Authors: Krishnamurthy H.; Jayaraman V.; Krishna K.; Wang T.; Bei K.; Suresh C.; Matilda S.; Rai A.; Welc-Falęciak R.; Pawełczyk A.; et al.
    Journal: Research Square

 

  • Title: Multi-Criterion Analysis of the Effect of Physico-Chemical Microbiological Agents on Legionella Detection in Hotel Water Distribution Systems in Crete
    Authors: Dimosthenis Chochlakis; Vassilis Sandalakis; Alexandros Ntoukakis; Maria-Olga Daskalaki; Thibaud Loppinet; Niki Thalassinaki; Rafaela Makridaki; Christos Panoulis; Anna Psaroulaki
    Journal: Frontiers in Cellular and Infection Microbiology

 

  • Title: Electrochemical Antigenic Sensor for the Diagnosis of Chronic Q Fever
    Authors: Eleni Mathioudaki; Yannis Alifragis; Maria Fouskaki; Dimosthenis Chochlakis; Haimin Xie; Anna Psaroulaki; Georgios Tsiotis; Nicholas Chaniotakis
    Journal: Current Research in Biotechnology

 

  •  Title: Giant Cell Arteritis Associated with Acute Q Fever – A Case Report
    Authors: Evangelia Sarra; Christos C. Mylonas; Georgios Tsekes; Dimosthenis Chochlakis; Anna Psaroulaki; Maria Chini
    Journal: Journal of Infection and Chemotherapy

CONCLUSION

Dr. Dimosthenis Chochlakis stands at the forefront of the Epidemiology of Emerging infectious diseases research. His legacy reflects decades of impactful contributions in pathogen surveillance, academic mentorship, and scientific inquiry. He combines academic excellence with public health urgency to respond to the Epidemiology of Emerging microbial threats. As new challenges evolve, his work remains essential for predictive modeling, diagnostic enhancement, and the control of Epidemiology of Emerging zoonotic and environmental diseases. He serves as an invaluable bridge between laboratory science and field epidemiology in addressing the Epidemiology of Emerging risks. His passion for microbiology, teaching, and innovation keeps him deeply engaged in improving responses to the Epidemiology of Emerging crises. Dr. Chochlakis continues to inspire global scientific communities through his leadership in the Epidemiology of Emerging pathogens domain and his strategic vision for public health resilience. His continued research will undoubtedly enhance the preparedness and response to the Epidemiology of Emerging threats worldwide.

Somdeb Bose Dasgupta – Microbial Pathogenesis and Virulence – Best Researcher Award

Somdeb Bose Dasgupta - Microbial Pathogenesis and Virulence - Best Researcher Award

IIT Kharagpur - India

AUTHOR PROFILE 

SCOPUS

EARLY ACADEMIC PURSUITS 🎓

Dr. Somdeb Bose Dasgupta began his scientific journey with a B.Sc in Physiology, Chemistry, and Zoology from City College, University of Calcutta, graduating with first-class honors in 2001. He pursued an M.Sc in Biophysics & Molecular Biology from Rajabazar Science College, University of Calcutta, and again secured first-class distinction. His academic rigor culminated in a Ph.D. in Molecular Parasitology from CSIR-IICB and Jadavpur University in 2009, where he was awarded the Best Thesis Award. During his doctoral years, Dr. Dasgupta delved deep into the molecular machinery of parasitic organisms, setting the foundation for a career that would be defined by his dedication to host-pathogen interactions. The exceptional clarity and originality of his doctoral research earned him early recognition in India’s scientific community, establishing a trajectory toward pioneering work in infectious diseases and immunology, especially concerning neglected tropical diseases like Leishmaniasis and Tuberculosis.

PROFESSIONAL ODYSSEY 🌍

Following his doctorate, Dr. Dasgupta expanded his scientific horizon through a postdoctoral fellowship at the University of Basel’s Biozentrum in Switzerland, from 2009 to 2014, where he worked on macrophage-pathogen interactions. This global exposure refined his research methodologies and enriched his understanding of molecular immunology. He then returned to India to contribute as an Assistant Professor at IIT (BHU) Varanasi from 2014 to 2016, before joining IIT Kharagpur in the Department of Biotechnology in 2016. At IIT Kharagpur, he rose to the position of Assistant Professor Grade I and became a pivotal figure in both undergraduate and postgraduate teaching. His courses span Molecular Biology, Neurophysiology, Biochemistry, and Bioprocess Engineering, nurturing the next generation of biotechnologists. His professional odyssey reflects a balance between international research excellence and a deep-rooted commitment to Indian scientific development. Throughout, he has maintained a clear vision: to translate basic science into therapeutic and diagnostic breakthroughs against life-threatening infectious diseases.

RESEARCH FOCUS 🔬

Dr. Dasgupta’s research lies at the intersection of molecular immunology, cellular microbiology, and genome editing. His lab investigates host-pathogen dynamics, especially in Mycobacterium tuberculosis and Leishmania donovani infections—diseases of critical importance to the Indian subcontinent. Utilizing CRISPR/Cas9 technologies, his team uncovers how host enzymes, particularly kinases and phosphatases, are manipulated by pathogens to ensure survival. His group is innovating host-directed therapeutics to bypass drug resistance by reactivating immune responses and restoring macrophage functionality. His approach includes drug repurposing strategies—like testing tricyclic antidepressants for anti-leishmanial use—and developing novel diagnostics for drug-resistant TB. Additionally, Dr. Dasgupta studies how parasitic infections influence phagosome maturation and immune modulation. His projects explore everything from biochemical pathway elucidation to advanced nanocarrier-based drug delivery systems. By combining cellular, biochemical, and genomic strategies, his lab offers crucial insights into both fundamental disease biology and translational medicine, with the aim of improving public health outcomes across endemic regions.

PIONEERING CONTRIBUTIONS 🧪

Over his career, Dr. Dasgupta has contributed over 38 research articles, five book chapters, and 25 conference proceedings, with many featured in high-impact journals like PNAS, FEBS Journal, and PLOS Pathogens. His pioneering findings—such as the discovery of how S-nitrosylation of mycobacterial Protein Kinase G (PknG) aids pathogen survival—have received global attention, including journal cover highlights and editor’s choice selections. At the forefront of translational research, he developed groundbreaking assays to study host-pathogen phospho-signaling, designed nanocarrier systems for immunomodulatory drug delivery, and repurposed common drugs into potential antiparasitic treatments. His innovations in CRISPR-based gene editing of host and pathogen genomes have redefined therapeutic targets. Further, his role in establishing India’s hybrid BSL-III facility at IIT Kharagpur has paved the way for safe, cutting-edge research on high-risk pathogens. Collectively, Dr. Dasgupta’s work bridges discovery and application, positioning him as a vanguard of molecular parasitology and infectious disease biology.

AWARDS AND RECOGNITION 🏅

Dr. Dasgupta’s scholarly excellence has been widely acknowledged. He was honored with the prestigious INSA Young Scientist Award in 2011 for contributions to biophysics and biochemistry, followed by the coveted DBT-Ramalingaswamy Fellowship in 2015. His postdoctoral research earned him the EMBO Long Term Fellowship in 2009, reflecting international acclaim. He has received multiple Best Poster Awards at national and international symposia, including the Annual Post-doc Retreats in Switzerland and the National Congress of Parasitology in India. His publications have been featured on journal covers and spotlighted for editorial distinction. He also received a DBT-CTEP Travel Award to attend the World Congress in Infectious Diseases in London, showcasing his global scientific presence. These accolades underscore both the depth and societal impact of his research. Through sustained excellence in discovery, innovation, and mentorship, Dr. Dasgupta has become a beacon in the field of molecular microbiology and immunopathology, inspiring peers and proteges alike.

IMPACT AND INFLUENCE 🌐

Dr. Dasgupta’s influence extends beyond laboratory research into public health, diagnostics, and therapeutic development. His contributions are instrumental in tackling antimicrobial resistance—one of modern medicine’s gravest challenges. By advancing host-directed therapies and creating rapid point-of-care diagnostic tools, he directly impacts clinical strategies for TB and Leishmaniasis. His leadership in major government-funded projects—ranging from ICMR, DST, DBT, to SERB—demonstrates trust in his ability to deliver translational outcomes. His work has informed national health priorities and contributed to India’s strategic push toward self-reliance in infectious disease control. As a mentor and educator, he shapes future scientists, embedding translational thinking in their academic DNA. His integrated approach, which combines molecular biology, nanotechnology, and immunology, sets a benchmark for interdisciplinary biomedical research in India. Through his visionary projects and collaborations, Dr. Dasgupta is not only solving today's biomedical problems but also laying the groundwork for long-term scientific resilience and healthcare innovation.

LEGACY AND FUTURE HORIZONS 🚀

Dr. Dasgupta’s legacy lies in transforming how we understand and combat chronic infectious diseases in resource-limited settings. His work champions a paradigm shift—from pathogen-centric drug design to host-targeted intervention, which offers sustainable solutions in the face of evolving drug resistance. The upcoming years promise even greater impact: his team is pioneering biosensors for non-invasive TB detection and leveraging liposomal drug delivery platforms for improved efficacy. With multiple ICMR-backed projects underway, including ENLIGHTEN—a non-invasive latent TB detection initiative—Dr. Dasgupta continues to chart untraveled paths in diagnostic science. He also plays a central role in shaping high-containment laboratory infrastructure to safely study dangerous pathogens. His foresight, collaborative spirit, and relentless pursuit of translational relevance ensure that his contributions will endure in both academic and clinical domains. Dr. Somdeb Bose Dasgupta is poised to remain a cornerstone of biomedical innovation, where his science continues to illuminate pathways toward global health equity.

NOTABLE PUBLICATION 

 Article Title:
Resolving the polycistronic aftermath: Essential role of topoisomerase IA in preventing R-loops in Leishmania
Authors: P. Das, A. Hazra, S. Saha, H.K. Majumdar, S. BoseDasgupta
Journal: The Journal of Biological Chemistry, 2024

 Article Title:
Gelatin-decorated Graphene oxide: A nanocarrier for delivering pH-responsive drug for improving therapeutic efficacy against atherosclerotic plaque
Authors: S.K. Yadav, S. Das, A. Lincon, S.K. Ray, S.C. Das
Journal: International Journal of Pharmaceutics, 2024